MedPath

Medrx USA, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.medrxusa.com

Clinical Trials

5

Active:0
Completed:5

Trial Phases

1 Phases

Phase 3:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 3
5 (100.0%)

Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness

Phase 3
Completed
Conditions
Acute Delayed Onset Muscle Soreness (DOMS)
Interventions
Drug: Placebo
Drug: Etodolac-lidocaine topical patch
First Posted Date
2016-03-01
Last Posted Date
2016-09-12
Lead Sponsor
MEDRx USA, Inc.
Target Recruit Count
100
Registration Number
NCT02695381
Locations
🇺🇸

Lotus Clinical Research, Pasadena, California, United States

Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain

Phase 3
Completed
Conditions
Low Back Pain
Interventions
Drug: Placebo
Drug: Etoreat®(Etodolac-Lidocaine Topical Patch)
First Posted Date
2013-10-23
Last Posted Date
2018-01-17
Lead Sponsor
MEDRx USA, Inc.
Target Recruit Count
232
Registration Number
NCT01968005

Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

Phase 3
Completed
Conditions
Tendonitis
Bursitis
Shoulder Pain
Interventions
Drug: MRX-7EAT
First Posted Date
2012-01-09
Last Posted Date
2018-01-16
Lead Sponsor
MEDRx USA, Inc.
Target Recruit Count
210
Registration Number
NCT01506154

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Phase 3
Completed
Conditions
Ankle Sprains
Interventions
Drug: MRX-7EAT
Drug: Placebo
First Posted Date
2010-09-10
Last Posted Date
2018-01-17
Lead Sponsor
MEDRx USA, Inc.
Target Recruit Count
600
Registration Number
NCT01198834

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Phase 3
Completed
Conditions
Acute Tendonitis
Bursitis
Interventions
Drug: Placebo
Drug: MRX-7EAT
First Posted Date
2010-07-13
Last Posted Date
2018-01-17
Lead Sponsor
MEDRx USA, Inc.
Target Recruit Count
350
Registration Number
NCT01161615

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.